Department of Defense Study Finds Risk of Exposure To COVID-19 Is Almost Non-Existent on United Flights

Thu, 10/22/2020 - 11:35

The results are in: Your risk of exposure to COVID-19 is almost non-existent on our flights (yes, even on a full flight).

Medtronic Donates Nearly $1 Million in Personal Protective Equipment to International Medical Corps for COVID-19 Response Efforts

Fri, 10/09/2020 - 13:00

Medtronic Donates Nearly $1 Million in Personal Protective Equipment to International Medical Corps for COVID-19 Response Effort

Johnson & Johnson Joins Other Companies in Signing a Landmark Communiqué on Expanded Global Access for COVID-19

Fri, 10/02/2020 - 12:30

In signing the communiqué, Johnson & Johnson and 15 other life science companies are committing to prioritize the safety, science and accessibility of the potential vaccines, therapeutic medicines or diagnostic tools they are developing to help fight the pandemic.

The Impact of COVID-19 on a Company: 6 Questions for the Chief Financial Officer of Johnson & Johnson

Thu, 10/01/2020 - 14:00

When you're the CFO of a company, you have a holistic view of how a pandemic can touch every aspect of a business, especially when it's a healthcare company. So we posed inquiring mind questions to Joe Wolk about what the past eight months have been like for him at the financial helm of the company—via a Zoom interview.

[WEBINAR] Reimagining Community Health Systems: Join SAP, Medtronic Foundation, and Leading Nonprofits in Community Health (Thurs, 10/15, 12 - 1 EDT)

Wed, 09/30/2020 - 16:30

Come get a glimpse of how the world can be reimagined toward a much stronger future with your help.

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate

Mon, 09/28/2020 - 16:35

Johnson & Johnson (NYSE: JNJ) (the Company) recently announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.

The Next Phase of Our COVID-19 Vaccine Development

Tue, 09/29/2020 - 12:30

We’re pleased to announce that based on interim results from our ongoing studies, the Janssen Pharmaceutical Companies of Johnson & Johnson are launching ENSEMBLE, a large-scale, multi-country Phase 3 trial of a single dose of our vaccine candidate.

The Road to a Vaccine, Season 2, Ep. 7: Is It Really Safe for Schools to Be Open Right Now?

Thu, 09/24/2020 - 14:20

As schools reopen—and sometimes close again—what have we learned about the risks of in-person learning? Lisa Ling speaks to school nurse Robin Cogan and pediatrician Dr. Sam Maldonado to find answers and debunk myths around kids and COVID-19.

The Road to a Vaccine, Season 2, Ep. 6: Everything You Need to Know about COVID-19 Testing and Contact Tracing

Thu, 09/17/2020 - 13:30

Alkermes Presents New Psychiatry Data at Psych Congress 2020 Virtual Experience

Tue, 09/15/2020 - 13:30

"We were pleased to share new research at this year's virtual Psych Congress, underscoring Alkermes' commitment to addressing the challenges faced by those living with serious mental illness," said Amy O'Sullivan, Vice President, Health Economics and Outcomes Research at Alkermes.